Inhibikase posts corporate presentation; no material updates disclosed

Inhibikase Therapeutics, Inc.

Company made corporate presentation available on April 21, 2022 via its website.
Presentation covers clinical development of disease-modifying therapeutics for Parkinson's and related disorders.
Filing contains no new financial or operational data; presentation content not fully available in the 8-K.
No specific pipeline milestones, revenue, or guidance changes reported.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.